Dual Antigen Targeting May Improve CAR T Cell Cancer Therapy
Chimeric antigen receptor T cells (CAR T cells) are a promising immunotherapy approach to cancer treatment in which a patient's own immune cells attack tumors by targeting an identifying marker, or…